Skip to main content

Table 2 Age-standardized screening, incidence, postoperative complication, and mortality rates of TC by income quintiles in Korea, 2006–2015

From: Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study

Age-standardized ratea Year Overall Income Q1 (lowest) Income Q2 Income Q3 Income Q4 Income Q5 (highest)
Screening
prevalence
Mid 2008
-mid 2010
12,562.0 (12,415.9–12,708.0) 8824.2 (8515.1–9133.3) 10,084.2 (9781.0–10,387.5) 11,487.7 (11,180.1–11,795.2) 13,057.9 (12,734.2–13,381.6) 17,675.7 (17,317.5–18,033.9)
Mid 2010
-mid 2012
17,449.9 (17,279.2–17,620.6) 11,506.9 (11,161.8–11,852.0) 13,612.7 (13,263.2–13,962.3) 16,305.0 (15,933.0–16,677.0) 18,874.5 (18,494.1–19,254.8) 24,439.6 (24,020.1–24,859.1)
Mid 2012
-mid 2014
18,717.5 (18,540.9–18,894.2) 11,977.5 (11,606.0–12,349.0) 14,934.3 (14,574.5–15,294.0) 17,118.8 (16,741.1–17,496.4) 20,138.9 (19,748.2–20,529.6) 26,110.0 (25,675.6–26,544.5)
Incidence rate 2006 46.6 (45.8–47.3) 36.4 (35–37.8) 37.8 (36.4–39.3) 42.7 (41.2–44.3) 50.2 (48.5–51.9) 66.0 (64.1–68.0)
2007 58.7 (57.9–59.6) 43.9 (42.3–45.5) 47.3 (45.7–48.9) 55.0 (53.2–56.7) 66.3 (64.3–68.2) 81.6 (79.4–83.7)
2008 73.7 (72.8–74.6) 53.7 (52.0–55.4) 59.1 (57.3–60.9) 68.0 (66.1–70.0) 83.6 (81.5–85.7) 104.2 (101.9–106.6)
2009 88.7 (87.7–89.6) 63.6 (61.8–65.4) 73.5 (71.6–75.5) 82.1 (80.0–84.2) 99.8 (97.5–102.1) 124.4 (121.9–127.0)
2010 95.4 (94.4–96.4) 69.5 (67.6–71.4) 79.6 (77.5–81.6) 90.1 (88.0–92.3) 106.4 (104.0–108.8) 131.4 (128.8–134.1)
2011 105.8 (104.8–106.9) 78.0 (76.1–80.0) 91.3 (89.2–93.5) 104.0 (101.7–106.3) 119.1 (116.6–121.5) 136.8 (134.2–139.4)
2012 115.0 (113.9–116) 84.8 (82.8–86.9) 100.1 (97.8–102.3) 113.3 (110.9–115.7) 128.3 (125.8–130.9) 148.3 (145.6–151.0)
2013 110.5 (109.4–111.5) 81.0 (79.0–83.0) 97.8 (95.6–100.1) 108.0 (105.7–110.4) 125.9 (123.4–128.4) 139.6 (136.9–142.2)
2014 81.7 (80.8–82.6) 63.4 (61.6–65.1) 75.5 (73.6–77.5) 81.5 (79.5–83.5) 91.2 (89.1–93.3) 97.2 (95.0–99.4)
2015 63.5 (62.7–64.2) 50.5 (49.0–52.1) 58.4 (56.7–60.1) 63.5 (61.8–65.3) 71.3 (69.5–73.2) 73.4 (71.5–75.3)
Postoperative complication rate 2006 8.9 (8.6–9.2) 6.5 (5.9–7.1) 7.7 (7.0–8.4) 8.4 (7.8–9.1) 9.9 (9.1–10.6) 12.0 (11.2–12.9)
2007 10.2 (9.8–10.5) 7.9 (7.2–8.5) 8.1 (7.4–8.7) 10.3 (9.6–11.1) 11.7 (10.9–12.5) 12.9 (12.1–13.8)
2008 12.4 (12.1–12.8) 10.0 (9.3–10.8) 10.6 (9.8–11.4) 12.3 (11.5–13.1) 13.4 (12.5–14.2) 15.8 (14.9–16.7)
2009 15.5 (15.1–15.9) 12.4 (11.6–13.2) 13.7 (12.9–14.6) 15.4 (14.5–16.3) 16.5 (15.6–17.5) 19.2 (18.2–20.2)
2010 19.0 (18.5–19.4) 15.2 (14.3–16.1) 17.4 (16.4–18.3) 18.8 (17.8–19.7) 20.2 (19.2–21.3) 23.2 (22.1–24.3)
2011 14.9 (14.5–15.3) 11.6 (10.9–12.4) 13.9 (13.0–14.7) 14.8 (14.0–15.7) 16.2 (15.3–17.1) 17.8 (16.8–18.7)
2012 17.9 (17.5–18.4) 15.3 (14.4–16.2) 16.4 (15.5–17.3) 18.1 (17.2–19.1) 19.3 (18.3–20.3) 20.6 (19.6–21.6)
2013 19.7 (19.2–20.1) 15.9 (15.1–16.8) 18.0 (17.1–19.0) 20.1 (19.1–21.1) 21.7 (20.7–22.8) 22.5 (21.5–23.6)
2014 16.8 (16.4–17.2) 14.2 (13.4–15.1) 16.4 (15.5–17.3) 17.7 (16.7–18.6) 18.4 (17.5–19.4) 17.1 (16.2–18.0)
2015 10.7 (10.4–11.0) 9.6 (8.9–10.3) 9.8 (9.2–10.5) 11.3 (10.5–12.0) 12.1 (11.4–12.9) 10.5 (9.8–11.3)
Mortality rate 2006–2010 1.0 (1.0–1.1) 1.3 (1.1–1.4) 0.9 (0.8–1.0) 1.0 (0.9–1.1) 1.0 (0.9–1.1) 1.0 (0.9–1.1)
2011–2015 0.8 (0.8–0.9) 1.0 (0.9–1.1) 0.8 (0.7–0.9) 0.8 (0.7–0.9) 0.8 (0.7–0.9) 0.7 (0.7–0.8)
  1. aAge-standardized rates per 100,000 were presented with 95% confidence intervals
\